Overview

Safety and Efficacy of Prulifloxacin Versus Placebo in Traveler's Diarrhea

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The objective of this pivotal Phase III study is to investigate the safety and efficacy of prulifloxacin versus placebo in the treatment of subjects with acute bacterial gastroenteritis.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Fluoroquinolones
Prulifloxacin